ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)

$1.98 -0.0131 (-0.6573%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) News Sources

Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies

24-07-2026

yahoo.com

Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference

27-08-2026

yahoo.com

Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

14-09-2026

yahoo.com

Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors

17-09-2026

yahoo.com

Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy

29-09-2026

yahoo.com

Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND

30-09-2026

yahoo.com

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

01-10-2026

yahoo.com

Ernexa Therapeutics’ ERNA-101 Selected for Flash Talk Presentation at Nature Conferences’ Next-Generation Cancer Therapeutics Meeting Co-Hosted by MD Anderson Cancer Center

06-10-2026

yahoo.com

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

12-10-2026

yahoo.com

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

22-10-2026

yahoo.com

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) Sentiment Trend

0 25 50 75 100 87 87 87 87 91 74 77 88 82 81 24-07-2026 27-08-2026 14-09-2026 17-09-2026 29-09-2026 30-09-2026 01-10-2026 06-10-2026 12-10-2026 22-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) FAQs

toggle

What is the current price of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?

The current price of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is $1.98.


toggle

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) absolute price change since previous trading day?

The absolute price change of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) since the previous trading day is $-0.0131.


toggle

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) percentage price change since previous trading day?

The percentage price change of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) since the previous trading day is -0.6573%.


toggle

What is the most recent average sentiment score for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?

The most recent average sentiment score for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is 84 out of 100.


toggle

What is the most recent average sentiment for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?

The most recent sentiment for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is .


SEC-8K** Filing Available For ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.